Probiotics do not prevent relapse in Crohn's disease patients

Despite previous data showing beneficial effects, the probiotic Saccharomuces boulardii (S. boulardii) does not prevent clinical relapse in patients with Crohn's disease, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

As more people seek natural or non-drug ways to maintain their health, products containing probiotics have flooded the marketplace. While safe and tolerable, this study discovered that the probiotic S. boulardii does not appear to have any significant beneficial effects for patients with Crohn's disease who are already in remission.

In this randomized, double-blind, placebo-controlled trial, the probiotic yeast S. boulardii was tested as a preventive therapy in patients with moderately severe Crohn's disease who were currently in remission following steroid or salicylate therapies. At the end of the one-year follow-up period, 50 percent of patients had relapsed—47.5 percent in the S. boulardii group and, similarly, 53.2 percent in the . Further, the time-to-relapse was not statistically different between patients treated with S. boulardii or placebo.

While this probiotic showed no positive effects for Crohn's disease patients, further studies are needed to determine the potential of probiotics in other forms of IBD, such as ulcerative colitis, and pouchitis.

Probiotics are living , or microorganisms, that scientific research has shown to benefit an individual's health. S. boulardii, a probiotic made from a strain of yeast and sold in local drug stores or supermarkets in the form of capsules, has been demonstrated to be effective in the treatment of traveler's diarrhea, diarrhea occurring in subjects infected with the and the prevention of diarrhea associated with antibiotics.

add to favorites email to friend print save as pdf

Related Stories

Probiotics prevent diarrhoea related to antibiotic use

May 30, 2013

Probiotic supplements have the potential to prevent diarrhoea caused by antibiotics, according to a new Cochrane systematic review. The authors studied Clostridium difficile (C. difficile) infections in patients taking antibi ...

Impaired sleep ups risk of relapse in Crohn's disease

Aug 08, 2013

(HealthDay)—For patients with Crohn's disease (CD), but not ulcerative colitis, sleep impairment is associated with increased risk of relapse, according to a study published in the August issue Clinical Ga ...

Probiotics show potential to minimize C. difficile

Nov 13, 2012

(Medical Xpress)—New cases of C. difficile-associated diarrhea among hospitalized patients taking antibiotics can be reduced by two-thirds with the use of probiotics, according to new research published Monday in the Annals of ...

Recommended for you

Syria hit by flesh-eating maggot disease

7 hours ago

Three cases of myiasis have been reported near Damascus, marking the first appearance of the flesh-eating maggot disease in Syria, UN health experts said Friday.

Sperm can carry Ebola for 82 days: WHO

9 hours ago

Sperm can carry the Ebola virus for at least 82 days, the World Health Organization said Friday, urging men recovering from the disease to use condoms for three months after the onset of symptoms.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.